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PROSTATE CANCER
Effects of tertiary Gleason 
pattern 5 on oncological outcome
Sean R. Williamson and Liang Cheng
Refers to Lucca, I. et al. Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of 
biochemical recurrence and development of a prognostic model. Urol. Oncol. http://dx.doi.org/10.1016/j.urolonc.2014.08.011
The prognostic implications of a tertiary component of Gleason pattern 5 
cancer at radical prostatectomy remain incompletely understood. 
A newly published study highlights the relationship between tertiary 
pattern 5 cancer, other risk factors and clinical outcomes. Authors 
propose a prognostic model to identify patients with the greatest need 
for adjuvant therapy.
The Gleason grading system has been 
recog nized for decades as a powerful tool 
for predicting the outcome of patients with 
prostate cancer; however, despite its wide-
spread use in clinical practice, uncertainty 
and debate over its applicability remain in a 
number of areas.1 For example, the signifi-
cance of a minor, higher grade or tertiary 
Gleason pattern, such as a small compo-
nent of Gleason pattern 5 in an otherwise 
Gleason score 7 cancer remains uncertain.
In a newly published, large, multicentre 
study of over 4,000 patients, Lucca and col-
leagues2 investigated the implications of 
tertiary Gleason pattern 5 in radical pros-
tatectomy specimens for the prediction of 
biochemical recurrence in patients with 
predominantly Gleason score 7 cancers. The 
authors used these data to create a prognos-
tic model for optimal clinical management 
of this heterogeneous group of patients.2
In 2005, many updates to the Gleason 
grading system were formalized, includ-
ing classification of several morphologic 
patterns as Gleason pattern 4.3 As a result 
of this formalization, incidence of Gleason 
score 7 cancer has increased in modern 
practice, and outcomes for these patients are 
highly variable. Some patients experience 
an outcome similar to that of Gleason 
score 3 + 3 = 6, whereas others progress to 
biochemical recurrence, metastasis and 
death from prostate cancer. When a minor 
Gleason pattern of higher grade than that 
detected in the majority of the tumour is 
present in prostate needle-biopsy speci-
mens, current guidelines require inclu-
sion of this higher-grade pattern in the 
Gleason score. Therefore, a tumour with 
a predominance of Gleason patterns 3 or 
4 and minor pattern 5 would be reported 
as either 3 + 5 = 8 or 4 + 5 = 9, an approach 
driven largely by the inability of prognostic 
nomograms and tables to account for a ter-
tiary pattern.3 However, extrapolating to the 
entire prostate gland, a substantial number 
of such patients are likely to have Gleason 
score 7 cancers with a minor fraction of 
the tumour composed of Gleason pattern 5 
in the gland as a whole. In this setting, the 
effect of such a tertiary pattern on bio-
chemical recurrence has been the subject 
of several studies over the past decade.4–9
Lucca et al.2 evaluate this challenge in a 
large, multicentre cohort of 4,146 patients, 
of whom 416 (10%) were found to have 
a tertiary Gleason pattern 5. The results 
suggest the presence of tertiary Gleason 
pattern 5 is associated with biochemical 
recurrence in both univariant and multi-
variant analyses. Standard clinical and path-
ological variables were adjusted for in the 
analyses, including preoperative serum PSA 
level, Gleason score, pathological stage and 
margin status.2 The authors propose a risk 
score for biochemical recurrence in patients 
with a tertiary Gleason pattern, rather than 
inherently considering the entire cohort as 
high-risk patients. The proposed risk strati-
fication tool takes into account serum PSA 
levels ≥10 (1 point), pathologic stage pT3b 
(1 point), positive surgical margin (1 point) 
and primary Gleason pattern 4 (2 points) as 
adverse f eatures. Under this stratification, 
patients with a low-risk score (0–1 point) 
had 5-year biochemical- recurrence-free 
survival of 76.3%, compared with 18.5% 
in the high-risk group (3–5 points).2 The 
authors hypothesize that, if validated by 
other studies, this high-risk group might be 
the most appropriate population for adju-
vant clinical trials, whereas for the low-
risk and intermediate-risk groups, serial 
PSA measurements could be employed to 
monitor long-term risk.2
The results of this investigation are largely 
similar to those found in other studies of 
the effect of a tertiary Gleason pattern on 
biochemical recurrence and cancer sur-
vival.4–8 In another concurrent, large study, 
2,396 (22.4%) of 11,226 consecutive patients 
undergoing radical prostatectomy had a ter-
tiary Gleason pattern.6 In this study, inclu-
sion criteria were less restrictive, as patients 
with other Gleason scores and lymph node 
metastases were also included.6 However, 
similar findings were reported, in that a 
tertiary Gleason pattern was found to be 
an independent predictor of biochemical 
recurrence in the subgroup of patients with 
Gleason score 7 tumours. Data from patient 
groups that were excluded from the study 
by Lucca and colleagues,2 (patients with 
‘‘…Lucca et al. providesadditional evidence for the 
prognostic value of a tertiary 
Gleason pattern 5 component’’
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Gleason score 3 + 3 and a minor tertiary 
pattern 4 of <5% and patients with Gleason 
scores ≥8) were also analysed,6 and in this 
setting, a tertiary Gleason pattern was 
not found to be an independent predic-
tor of biochemical recurrence.6 Although 
patients who received adjuvant therapy 
were included in the analysis, statistical 
analysis excluding these patients yielded 
similar results.6
The combined fraction of high-grade 
cancer patterns is another parameter 
that has also been examined for predict-
ing outcome after radical prostatectomy 
(Gleason patterns 4 and 5 together).4,10 This 
combined proportion of high-grade cancer 
arguably has the greatest effect on progno-
sis at predominantly the high and low ends 
of the spectrum. However, one large study 
analysing this stratification found patients 
with greater than 20% high-grade cancer 
patterns to have a 10-year cancer-specific 
survival of 67%, compared with 85% for 
those with less than 20% Gleason patterns 4 
and 5, and 100% in those without any high-
grade component.10 The importance of 
the overall fraction of high-grade patterns 
is also highlighted by the predictive-risk 
score proposed by Lucca and co-work-
ers,2 in which a primary Gleason pattern 
of 4 receives the highest weighting of any 
single parameter.
As Lucca and colleagues2 note, although 
they examine a large cohort of patients, 
a centralized review of the pathology of 
study cases was not available to confirm 
and evaluate the presence and extent of 
the tertiary Gleason pattern. Pertinently, the 
authors define a tertiary Gleason pattern 
as comprising <5% of the entire tumour. 
No consensus currently exists on such a 
definition in the radical prostatectomy 
setting.1,3 For example, a tumour composed 
of 60% Gleason pattern 4, 30% Gleason 
pattern 3 and 10% Gleason pattern 5 at 
prostatectomy would be regarded by some 
pathologists as Gleason score 4 + 5 = 9 
(using the 5% cutoff), whereas others would 
regard the pattern 5 component as tertiary, 
regardless of extent, as long as it is the least 
prevalent of the three patterns. The latter 
approach has been used in several other 
studies evaluating tertiary Gleason pat-
terns, which might at least partly contrib-
ute to differences in study p opulations and 
outcomes.6,8,9
In summary, although the Gleason 
score is established as a powerful prog-
nostic tool in the management of prostate 
cancer, debate and uncertainty remain 
with respect to a number of aspects of its 
application. The study by Lucca et al.2 pro-
vides additional evidence for the prognostic 
value of a tertiary Gleason pattern 5 com-
ponent. Application of a novel prognostic 
model, including the use of a combined 
percentage of Gleason pattern 4 and 5, 
might improve the clinical management of 
patients with prostate cancer, if validated in 
future studies.
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